Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Bafna Pharmaceuticals IPO.
November 13, 2024 6:03:00 PM
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their ...
Published by : moneycontrol.comNovember 14, 2024 7:13:00 PM
Bafna Pharmaceuticals Ltd share price was up by 1.20% from the previous closing price of ?79.05. Who are peers of Bafna Pharmaceuticals Ltd? The peers of Bafna Pharmaceuticals Ltd are Sun ...
Published by : Business TodaySeptember 17, 2024 4:30:00 AM
The Board Meeting to be held on 11/11/2024 has been revised to 11/11/2024 BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on ...
Published by : money.rediffOctober 3, 2024 4:30:00 AM
Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of ...
Published by : India InfolineMarch 4, 2018 2:50:00 PM
Bafna Pharmaceuticals has reported a sales standalone turnover of Rs 46.72 crore and a net profit of Rs 1.10 crore for the quarter ended Dec '13 Bafna Pharmaceuticals has reported a sales ...
Published by : moneycontrol.comApril 15, 2023 2:01:00 PM
Ramesh Bafna joins Zepto as chief financial officer ... metrics of the company are very strong. To this effect, the IPO planning process will be key for the company and its CFO.
Published by : Business Insider IndiaBafna Pharmaceuticals Ltd IPO Listing Info:
IPO Listing Date: Friday, June 27, 2008
BSE Script Code: 532989
Listing in: B Group of securities
ISIN: INE878I01014
Issue Price: Rs. 40/-
Face Value: Rs 10/- Per Equity Share
IPO Allotment Status is now available online for Bafna Pharmaceuticals Ltd IPO.
Issue was fixed price and will only list on BSE. Listing date will be available soon.
Incorporated in 1995, Bafna Pharmaceuticals Limited is engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
Bafna Pharmaceuticals Limited is entering in the capital markets with an initial public offering, IPO of 64,00,000 Equity Shares for cash, at the premium of Rs 30.
The price band for the issue has been fixed at Rs. 40/- for equity share of Rs. 10/-. The issue opens on May 27, 2008, and closes for subscription on May 30, 2008. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).
The Bafna Pharmaceuticals IPO is proposed to open on May 27, 2008. The IPO application ends on May 30, 2008.
Retail investors can apply in the retail or non-institutional investor category from May 27, 2008 to May 30, 2008. The Bafna Pharmaceuticals IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Bafna Pharmaceuticals IPO will open for subscription on May 27, 2008. The public issue will close on May 30, 2008.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
